Filing Details

Accession Number:
0000899866-17-000155
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-02 17:18:50
Reporting Period:
2017-07-31
Filing Date:
2017-08-02
Accepted Time:
2017-08-02 17:18:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1493023 M Ann Veneman C/O Alexion Pharmaceuticals, Inc
100 College Street
New Haven CT 06510
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Disposition 2017-07-31 700 $137.74 6,315 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.